50855-32-8 ((Xyloside)

Xyloside;D-Xylopyranose;Xylose (USP);D-(+)-Xylose, BioUltra, >=99.0% (sum of enantiomers, HPLC);7261-26-9;Wood sugar;CS-0083551;DTXCID903745;Xylomed;D-(+)-Xylose, puriss., 98.5%;Xylose, European Pharmacopoeia (EP) Reference Standard;SMR000857378;Tox21_302055;D(+)-XYLOSE;(3R,4S,5R)-oxane-2,3,4,5-tetrol;d-(+)-Xylose;Xylo-Pfan;MLS001361339;Xylo-Pfan (TN);Xylose, pure;(3R,4S,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol;Xylopyranoside;xylo-pentose;F8887-9207;Xyl;BDBM16234;BRN 1562108;AKOS025401342;CHEMBL502135;AC-11300;MFCD00064360;CHEBI:53455;AS-11757;Xylopyranose (6CI,7CI,8CI,9CI);WURCS=2.0/1,1,0/(a212h-1x_1-5)/1/;CAS-58-86-6;D-xylopentose;50855-32-8;rel-(3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol;CHEBI:18222;D-(+)-Xylose, 99%, natural sourced;EN300-118961;NCGC00255319-01;Xylose, United States Pharmacopeia (USP) Reference Standard;D-Xyl;Xylose;SRBFZHDQGSBBOR-IOVATXLUSA-N;D06346;DTXSID0023745;(3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol;NCGC00165998-01;D-Xylose;SCHEMBL39891;cid_135191;Xylopyranose;CHEBI:65327;D-(+)-Xylose, >=99%;C00181;D-(+)-Xylose, analytical standard;D-(+)-Xylose, SAJ special grade, 98.0-101.0%;Z1255356270;AI3-19010;G72648;D Xylose;D-(+)-Xylose, BioXtra, >=99%;10257-31-5;D-Xylopyranoside;Epitope ID:114701;

SRBFZHDQGSBBOR-IOVATXLUSA-N

1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m1/s1

O1C[C@H]([C@@H]([C@H](C1O)O)O)O